BioVie Inc. Warrant
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to mo… Read more
BioVie Inc. Warrant (BIVIW) - Total Assets
Latest total assets as of September 2025: $26.82 Million USD
Based on the latest financial reports, BioVie Inc. Warrant (BIVIW) holds total assets worth $26.82 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioVie Inc. Warrant - Total Assets Trend (2021–2025)
This chart illustrates how BioVie Inc. Warrant’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioVie Inc. Warrant - Asset Composition Analysis
Current Asset Composition (June 2025)
BioVie Inc. Warrant's total assets of $26.82 Million consist of 96.0% current assets and 4.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 81.4% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $178.34K | 0.8% |
| Goodwill | $345.71K | 1.6% |
Asset Composition Trend (2021–2025)
This chart illustrates how BioVie Inc. Warrant's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioVie Inc. Warrant's current assets represent 96.0% of total assets in 2025, an increase from 76.2% in 2021.
- Cash Position: Cash and equivalents constituted 81.4% of total assets in 2025, up from 74.6% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 23.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 1.6% of total assets.
BioVie Inc. Warrant Competitors by Total Assets
Key competitors of BioVie Inc. Warrant based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
BioVie Inc. Warrant - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BioVie Inc. Warrant generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BioVie Inc. Warrant is currently not profitable relative to its asset base.
BioVie Inc. Warrant - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 15.83 | 2.95 | 2.45 |
| Quick Ratio | 15.83 | 2.95 | 2.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $24.39 Million | $ 13.31 Million | $ 18.06 Million |
BioVie Inc. Warrant - Advanced Valuation Insights
This section examines the relationship between BioVie Inc. Warrant's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -14.5% |
| Total Assets | $21.56 Million |
| Market Capitalization | $3.28K USD |
Valuation Analysis
Below Book Valuation: The market values BioVie Inc. Warrant's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BioVie Inc. Warrant's assets decreased by 14.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BioVie Inc. Warrant (2021–2025)
The table below shows the annual total assets of BioVie Inc. Warrant from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $21.56 Million | -14.46% |
| 2024-06-30 | $25.21 Million | -28.19% |
| 2023-06-30 | $35.10 Million | +74.52% |
| 2022-06-30 | $20.11 Million | +232.65% |
| 2021-06-30 | $6.05 Million | -- |